Is acute myeloid leukemia treatment possible without transplant?

Yes, for favorable-risk AML or elderly patients unfit for transplant, chemotherapy with or without targeted therapy can achieve remission.

What is the AML transplant success rate?

With matched donors and early transplant during first remission, success rates range between 50%–70% depending on age, risk factors, and MRD status.

How long does acute myeloid leukemia (AML) treatment take?

Induction chemotherapy usually takes 4–6 weeks. Consolidation or transplant requires another 4–8 weeks. Post-transplant recovery may last several months.

How is acute myeloid leukemia (AML) different from chronic myeloid leukemia (CML)?

AML is acute and aggressive, requiring immediate intensive therapy. CML is a chronic disease often managed long-term with oral targeted drugs like imatinib

What is acute myeloid leukemia (AML) remission treatment?

It includes post-chemotherapy or post-transplant follow-up, MRD monitoring, immunosuppression tapering, and infection prevention to avoid relapse.

Is acute myeloid leukemia (AML) common in India?

Yes, AML is one of the most common acute leukemias in adults, and its incidence is rising in urban populations.

Can children get AML?

Yes. AML in children and adolescents requires pediatric-specific treatment protocols and is managed by our expert pediatric oncology team.

What is acute lymphocytic leukemia (ALL)?

ALL is a fast-growing cancer of the bone marrow and blood that affects lymphoid precursor cells. It occurs in both children and adults and requires immediate, specialized treatment.

What are the early symptoms of Acute Lymphocytic Leukemia (ALL)

Common symptoms include fatigue, infections, bruising or bleeding, bone pain, and swollen lymph nodes. Prompt diagnosis is essential.

How is ALL diagnosed at BMT Next?

We use CBC, bone marrow biopsy, flow cytometry, cytogenetics (e.g., BCR-ABL1), MRD testing, and next-generation sequencing to confirm the diagnosis and subtype.

What is the success rate for pediatric Acute Lymphocytic Leukemia (ALL) at BMT Next?

In standard-risk pediatric ALL, our survival rates exceed 94%, aligning with top international benchmarks.

What is the role of bone marrow transplant in ALL?

BMT is offered to patients with high-risk features, poor response to induction therapy, relapsed disease, or specific cytogenetic abnormalities like Ph+ ALL.

Can adults with ALL also be treated at BMT Next?

Yes. We treat adult ALL using age-adapted protocols and offer reduced-intensity transplant regimens when needed.

What targeted therapies do you offer for relapsed or refractory Acute Lymphocytic Leukemia (ALL)?

We provide access to Blinatumomab (BiTE), Inotuzumab ozogamicin, and TKIs for Ph+ ALL. CAR-T therapy is coordinated with leading centers in India.

How does BMT Next support international patients from Mauritius or Africa?

We offer virtual consultations, visa and travel assistance, multilingual care coordination, and continuity of treatment between India and Mauritius.

Is CAR-T cell therapy available for Acute Lymphocytic Leukemia (ALL)at BMT Next?

Yes. We collaborate with accredited CAR-T therapy partners to treat CD19+ relapsed/refractory ALL cases.

How is MRD testing used to guide treatment?

MRD (Minimal Residual Disease) testing after induction and consolidation phases helps assess treatment effectiveness and guides the need for BMT.

What are the side effects of chemotherapy for Acute Lymphocytic Leukemia (ALL)?

Side effects include neutropenia, infections, nausea, hair loss, and fatigue. We manage toxicity through supportive care and growth factor use.

Do you provide fertility preservation for young ALL patients?

Yes. We offer fertility counseling and options like sperm banking and ovarian tissue preservation before intensive chemotherapy or transplant.

How long is treatment for acute lymphocytic leukemia?

Pediatric ALL treatment typically lasts 2–3 years. Adult protocols are shorter but may include transplant or advanced therapies.

What makes BMT Next different from other leukemia centers?

We provide MRD-guided treatment, access to immunotherapy and transplant, global referrals, and unmatched survival outcomes in India.

How can I book a second opinion at BMT Next?

You can request a virtual or in-person second opinion by sharing your reports through our patient portal or contacting our coordination team directly.

Why is BMT Next considered the best center for acute lymphocytic leukemia (ALL) treatment in Gurgaon (Gurugram)?

BMT Next in Gurgaon is equipped with advanced genomic testing, CAR-T therapy access, expert-led transplant services, and participation in international clinical trials. It offers personalized care for both pediatric and adult ALL patients, combining technology, experience, and outcomes that meet global standards.

What is multiple myeloma and how is it different from other blood cancers?

Multiple myeloma is considered a cancer of plasma cells, a type of white blood cell that helps fight infection. Unlike leukemia or lymphoma, it majorly affects the bone marrow and skeletal system.

What are the early signs of multiple myeloma?

Early signs include persistent bone pain, frequent infections, unexplained fatigue, anemia, kidney dysfunction, and high calcium levels.

How is multiple myeloma diagnosed at BMT Next?

We use a combination of blood tests (SPEP, IFE, FLC), bone marrow biopsy, PET-CT or MRI, and FISH cytogenetic studies to confirm diagnosis and risk stratify the disease.

What is the role of FISH cytogenetics in myeloma diagnosis?

FISH identifies genetic abnormalities like del(17p), t(4;14), or 1q gain, which help us predict prognosis and customize treatment.

Is bone marrow transplant mandatory for all myeloma patients?

No. Autologous stem cell transplant (ASCT) is recommended for eligible patients to prolong remission, but alternatives exist for transplant-ineligible individuals.

What is CAR-T therapy and is it available at BMT Next?

CAR-T therapy involves genetically modifying a patient’s own T-cells to fight myeloma. It is available through clinical access programs at BMT Next.

. What are the treatment options for relapsed or refractory myeloma?

Options include immunomodulators like Pomalidomide, monoclonal antibodies like Daratumumab, BiTE therapies, and CAR-T cells.

How does BMT Next monitor treatment response?

We use MRD (minimal residual disease) testing via flow cytometry or NGS to monitor the depth of remission after treatment.

Are there different types of multiple myeloma?

Yes, including smoldering myeloma (asymptomatic), active myeloma (requiring treatment), and relapsed/refractory myeloma.

What support services are offered at BMT Next for myeloma patients?

Patients receive nutritional counseling, pain management, physiotherapy, renal care, and emotional wellness support throughout treatment.

What makes BMT Next the best center for multiple myeloma treatment in India?

BMT Next offers the best multiple myeloma treatment in India through its expert-led centers in Gurgaon, Hisar, Faridabad, and Mauritius. Our strength lies in bone marrow transplant excellence, MRD-based treatment, next-level FISH cytogenetics, and access to CAR-T and BiTE therapy. Patients across North India and internationally choose BMT Next for high-quality, affordable, and personalized plasma cell cancer treatment.

How can patients from Mauritius access myeloma care at BMT Next?

Our international patient desk helps with appointment scheduling, visa support, travel coordination, and follow-up teleconsultation.

How often should follow-up occur after myeloma treatment?

Follow-up is typically every 3–6 months with blood tests, MRD monitoring, and imaging when needed.

What is lenalidomide maintenance and why is it important?

Lenalidomide is used after transplant or initial therapy to maintain remission and delay progression. It is a cornerstone of long-term management.

Are affordable treatment packages available for myeloma at BMT Next?

Yes. We offer cost-effective care across Hisar, Faridabad, and Gurgaon with insurance, CGHS, and EMI support.

What is the success rate of bone marrow transplant in India?

At leading centers like BMT Next, the success rate for bone marrow transplant ranges between 70% to 90%, depending on the disease type, patient condition, and transplant match. Conditions like thalassemia, aplastic anemia, and acute leukemia show high cure rates when treated early.

How much does a bone marrow transplant cost in India?

The cost varies between ₹8 to ₹25 lakhs, based on the type of transplant. Autologous BMTs are usually less expensive than allogeneic or haploidentical transplants. BMT Next offers transparent packages in Gurgaon, Faridabad, Hisar, and Mauritius with financial counseling support.

How long does a bone marrow transplant take?

The full procedure—including pre-evaluation, transplant, and initial recovery—typically takes 4 to 6 weeks. Post-discharge monitoring continues for 6 to 12 months depending on the patient’s immune recovery.

Who can be a donor for bone marrow transplant?

Donors may be siblings, matched unrelated individuals, or half-matched (haploidentical) family members. At BMT Next, we conduct HLA typing and also work with global donor registries if a family match isn’t available

Is bone marrow transplant painful?

The transplant itself is not painful. It’s a stem cell infusion given through a vein, very similar to a blood transfusion. Pre-transplant chemotherapy may cause side effects, which are managed by our transplant care team.

Which diseases are treated with bone marrow transplant?

We treat leukemia, lymphoma, multiple myeloma, aplastic anemia, thalassemia, sickle cell anemia, MDS, and rare immunodeficiency syndromes. BMT Next specializes in both adult and pediatric BMTs across all these conditions.

Can international patients get bone marrow transplant in India?

Yes. Through our Mauritius center, international patients from Africa, the Middle East, and Indian Ocean islands can access India’s best BMT care with visa assistance, translator support, and telemedicine follow-up.

What are the risks of bone marrow transplant?

Like any major medical procedure, BMT carries risks such as infection, graft-versus-host disease (GVHD), and delayed engraftment. However, at BMT Next, we use strict infection control, ICU monitoring, and early GVHD management to minimize complications.

Why is BMT Next considered among the best bone marrow transplant centers in India?

With over 3,000+ transplants performed, MRD-guided therapy, internationally trained specialists, and a strong presence in Gurgaon, Faridabad, Hisar, and Mauritius, BMT Next combines experience with accessibility and affordability.

How soon should I consult for a bone marrow transplant?

Early consultation is critical—especially for high-risk leukemia, aplastic anemia, or relapsed cancers. Delays can affect survival. Contact BMT Next today to schedule a transplant evaluation at your nearest center.

Doctor Profile

Dr. Meet Kumar

Dr. Meet Kumar – Best Hematologist & Bone Marrow Transplant Specialist in Gurugram, Faridabad, Hisar (Haryana) & Mauritius

Leading Expert in Hemato-Oncology, Bone Marrow Transplants & Cancer Care

Dr. Meet Kumar is a highly acclaimed hematologist and bone marrow transplant specialist in Gurugram, Faridabad, Hisa r(Haryana) and Mauritius. With over 14 years of experience, he has successfully performed more than 1,000 bone marrow transplants across India and overseas. Dr. Kumar specializes in treating a wide range of blood disorders, including leukemia, lymphoma, myeloma, anemia, and aplastic anemia.

Dr. Meet Kumar’s professional journey has made him one of the most sought-after hematology oncologists in Gurugram, where he has worked at some of the leading hospitals, including Fortis Memorial Research Institute and Sir Ganga Ram Hospital. His advanced training in CART cell therapy and bone marrow transplant from Kings College London and Tata Medical Centre, Kolkata has positioned him as a pioneer in hemato-oncology care in India.Trust then best hematologist in gurugram, hisar, faridabad and mauritius.

Areas of Expertise in Hematology & Oncology

Bone Marrow Transplant (BMT) – Specialist in Autologous, Allogeneic, Matched Unrelated & Haplo-Identical BMTs

Dr. Kumar specializes in bone marrow transplants for patients with various blood cancers and blood disorders. He has extensive experience in both autologous (using the patient’s own cells) and allogeneic (using donor cells) transplants, including the haplo-identical and matched unrelated options. He is considered the best bone transplant specialist doctor in gurugram.

With over 1000 successful bone marrow transplants, Dr. Meet Kumar has become one of the leading experts in the area of hematology and bone marrow transplant (BMT) in India. Looking for the best bone marrow transplant specialist doctor, look no further!

Best Leukemia & Lymphoma Care in Haryana & Abroad

Dr. Meet Kumar is a recognized expert in the diagnosis and treatment of leukemia, lymphoma, and myeloma. He offers advanced oncology treatments, including chemotherapy, targeted therapy, and immunotherapy, customized to each patient’s condition.

Anaemia & Thrombocytopenia Treatment

Dr. Kumar treats various types of anaemia, including iron deficiency anaemia, sickle cell anaemia, and aplastic anaemia. His approach combines a thorough diagnostic process with the latest treatment options, including blood transfusions, iron therapy, and stem cell treatment.

Aplastic Anaemia – Comprehensive Care

Aplastic anaemia, a life-threatening condition that affects the bone marrow’s ability to produce blood cells, is one of Dr. Meet Kumar’s areas of expertise. He is known for offering the most advanced treatment options, including bone marrow transplants for patients with severe cases. Choose the best bone marrow transplant specialist doctor in Gurugram, Hisar, Faridabad and Mauritius.

Why Choose Dr. Meet Kumar?

1000+ Successful Bone Marrow Transplants: Dr. Kumar has completed over 1000+ bone marrow transplants, helping patients with blood cancers like leukemia, lymphoma, and myeloma.
Advanced Training in BMT & CART Cell Therapy: He has received training from world-class institutions, including Tata Medical Centre, Kolkata and Kings College London in Chimeric Antigen Receptor (CART) cell therapy.
Director & HOD – Hemato-Oncology and Bone Marrow Transplant: Dr. Kumar has served as Director & HOD in prestigious hospitals, leading teams that have provided exceptional care for hematology patients. Currently serving as HOD at the BMT Unit of Marengo Asia Hospitals, Gurugram.

Reputed Academic & Clinical Background: He completed his MBBS and MD from Jamnagar, College, Kolkata.
Recognition in the Field: Dr.Meet Kumar has received numerous prestigious awards like the Hisar Gaurav and Global Award for emerging as a top hematologist in India.

Educational Background and Training

Feel free in the expert care of the best hematologist in Gurugram, Hisar, Faridabad and Mauritius.

MBBS from Jamnagar, Gujarat
MD in Internal Medicine from Jamnagar, Gujarat
DM in Clinical Haematology from NRS Medical College, Kolkata
Fellowship in Bone Marrow Transplant from Tata Medical Centre, Kolkata
Observer in CART Cell Therapy from Kings College, London

Professional Experience

Dr. Meet Kumar has worked in leading hospitals across India, including:

Sir Ganga Ram Hospital, Delhi
SGPGI, Lucknow
BLK Hospital, Delhi
Kings College, London
Fortis Memorial Research Institute, Gurugram

He is also credited with establishing the first Bone Marrow Transplant Centre in any State Government hospital in Vadodara, Gujarat, marking a significant milestone in affordable cancer care for patients in India. With the best bone marrow transplant specialist doctor by your side, there’s no need to worry!

Professional Memberships & Awards

Dr. Kumar is actively involved in several prestigious medical organizations, including:

Indian Society of Hematology & Blood Transfusion (ISHBT)
American Society of Hematology (ASH)
Bengal Society of Hematology
Delhi Society of Hematology

He has also been recognized with numerous awards, including:

Hisar Gaurav Award
Global Award for Emerging Hematologist

Research & Publications

Dr. Meet Kumar has contributed to over 20 research publications in national & international journals of repute. He has participated in numerous medical conferences as a panelist, moderator, and chairperson, sharing his expertise in hematology and oncology treatments.

Book an Appointment with Dr. Meet Kumar

If you or a loved one requires treatment for blood disorders, blood cancers, or needs a bone marrow transplant, Dr. Meet Kumar offers world-class care. Reach out to the Best bone marrow transplant specialist doctor in Gurugram, Hisar, Faridabad and Mauritius. His expertise in hematology oncology and his patient-centered approach ensures the best possible outcomes.

Call now to schedule an appointment or consultation.

Phone Number: +91 92114 93630
Location:Marengo Asia Hospitals – Gurugram, Hisar, and Faridabad.

Doctor Profile

Dr. Meet Kumar

Dr. Meet Kumar – Best Hematologist & Bone Marrow Transplant Specialist in Gurugram, Faridabad, Hisar (Haryana) & Mauritius

Leading Expert in Hemato-Oncology, Bone Marrow Transplants & Cancer Care

Areas of Expertise in Hematology & Oncology

Bone Marrow Transplant (BMT) – Specialist in Autologous, Allogeneic, Matched Unrelated & Haplo-Identical BMTs

Best Leukemia & Lymphoma Care in Haryana & Abroad

Anaemia & Thrombocytopenia Treatment

Aplastic Anaemia – Comprehensive Care

Why Choose Dr. Meet Kumar?

Educational Background and Training

Professional Experience

Professional Memberships & Awards

Research & Publications

Book an Appointment with Dr. Meet Kumar

Need Help?

FAQs

What are the limitations of regular license?

Can I download the files after six months?

How to install the software on local machine?

How many months of free support is included?

Useful Links

Work Hours

Call us

Email